Isabelle Leclercq
Overview
Explore the profile of Isabelle Leclercq including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1903
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gillard J, Leclercq I
Clin Sci (Lond)
. 2024 Nov;
138(23):1521-1523.
PMID: 39589838
Over the past 20 years, basic research has robustly demonstrated the regulatory role of bile acids in physiological processes, primarily by the discovery and the study of their specific receptors...
2.
Henry A, Boigelot T, Ferreira de Moura T, Leclercq I, Barbe C, Thiery A, et al.
Diabetes Metab
. 2024 Apr;
50(3):101533.
PMID: 38570135
No abstract available.
3.
Maccioni L, Fu Y, Horsmans Y, Leclercq I, Starkel P, Kunos G, et al.
eGastroenterology
. 2023 Sep;
1(1).
PMID: 37662449
Excessive alcohol drinking can cause pathological changes including carcinogenesis in the digestive tract from mouth to large intestine, but the underlying mechanisms are not fully understood. In this review, we...
4.
Nachit M, Dioguardi Burgio M, Abyzov A, Garteiser P, Paradis V, Vilgrain V, et al.
Eur Radiol
. 2023 Sep;
34(3):1461-1470.
PMID: 37658893
Objectives: To evaluate the association between fat infiltration in skeletal muscles (myosteatosis) and hepatocellular carcinoma (HCC) in patients with non-alcoholic fatty liver disease (NAFLD). Methods: In a cross-sectional cohort of...
5.
Maccioni L, Horsmans Y, Leclercq I, Schnabl B, Starkel P
Alcohol Clin Exp Res (Hoboken)
. 2023 Apr;
47(6):1079-1087.
PMID: 37060262
Background And Aims: The progression of alcohol-associated liver disease (ALD) in its early precirrhotic stages can be a silent process. Serum keratin 18 levels (K18-M65) predict severe events and mortality...
6.
Maccioni L, Kasavuli J, Leclercq S, Pirlot B, Laloux G, Horsmans Y, et al.
Hepatol Commun
. 2023 Apr;
7(5).
PMID: 37058088
Background And Rationale: In the context of gut leakiness and translocation of microbial products in alcohol-associated liver disease (ALD), it is possible that systemic and liver inflammation involve the activation...
7.
Maccioni L, Loriot A, Dewulf J, Bommer G, Horsmans Y, Lanthier N, et al.
Aliment Pharmacol Ther
. 2022 Aug;
56(6):1055-1070.
PMID: 35919965
Background: Intestinal T cells are key in gut barrier function. Their role in early stages of alcohol-associated liver disease (ALD) remain unknown. Aim: To explore the links between intestinal T...
8.
Iesari S, Leclercq I, Joudiou N, Komuta M, Daumerie A, Ambroise J, et al.
Clin Sci (Lond)
. 2021 Sep;
135(19):2285-2305.
PMID: 34550341
Background: Small-for-size syndrome (SFSS) looms over patients needing liver resection or living-donor transplantation. Hypoxia has been shown to be crucial for the successful outcome of liver resection in the very...
9.
Nachit M, Horsmans Y, Leclercq I
JHEP Rep
. 2021 Mar;
3(2):100235.
PMID: 33748728
No abstract available.
10.
Courtoy G, Leclercq I, Froidure A, Schiano G, Morelle J, Devuyst O, et al.
Biomolecules
. 2020 Dec;
10(11).
PMID: 33266431
Current understanding of fibrosis remains incomplete despite the increasing burden of related diseases. Preclinical models are used to dissect the pathogenesis and dynamics of fibrosis, and to evaluate anti-fibrotic therapies....